2015 Q4 Form 10-Q Financial Statement

#000114420415065489 Filed on November 16, 2015

View on sec.gov

Income Statement

Concept 2015 Q4 2015 Q3 2014 Q3
Revenue $20.00K $108.7K $187.8K
YoY Change -91.67% -42.12% -45.48%
Cost Of Revenue $50.00K $321.8K $264.5K
YoY Change -91.07% 21.67% 102.23%
Gross Profit -$20.00K -$213.1K -$76.69K
YoY Change -93.75% 177.82% -130.58%
Gross Profit Margin -100.0% -196.04% -40.84%
Selling, General & Admin $610.0K $144.3K $2.095M
YoY Change -76.26% -93.11% 213.96%
% of Gross Profit
Research & Development $80.00K $92.86K $153.2K
YoY Change -63.64% -39.38%
% of Gross Profit
Depreciation & Amortization $130.0K $130.0K $130.0K
YoY Change 85.71% 0.0% 44.44%
% of Gross Profit
Operating Expenses $830.0K $365.6K $2.380M
YoY Change -70.88% -84.64% 117.03%
Operating Profit -$850.0K -$578.6K -$2.457M
YoY Change -73.19% -76.45% 190.42%
Interest Expense $100.0K $81.00 -$416.00
YoY Change -119.47% -102.64%
% of Operating Profit
Other Income/Expense, Net $0.00 $81.00 -$12.42K
YoY Change -100.65% -49.87%
Pretax Income -$750.0K -$580.0K -$2.470M
YoY Change -76.71% -76.52% 183.91%
Income Tax
% Of Pretax Income
Net Earnings -$750.0K -$578.5K -$2.470M
YoY Change -76.71% -76.57% 183.59%
Net Earnings / Revenue -3750.0% -532.31% -1315.21%
Basic Earnings Per Share
Diluted Earnings Per Share -$229.4K -$177.4K -$1.012M
COMMON SHARES
Basic Shares Outstanding 81.80M shares 61.06M
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q4 2015 Q3 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.740M $120.0K $2.200M
YoY Change 0.0% -94.55% 2344.44%
Cash & Equivalents $1.687M $51.91K $2.152M
Short-Term Investments $50.00K $60.00K $50.00K
Other Short-Term Assets $40.00K $80.00K $170.0K
YoY Change -55.56% -52.94%
Inventory
Prepaid Expenses
Receivables $22.74K $49.01K $400.0K
Other Receivables $0.00 $50.00K $30.00K
Total Short-Term Assets $1.805M $298.0K $2.800M
YoY Change -44.87% -89.36% 851.7%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Goodwill $700.5K $700.5K
YoY Change 0.0%
Intangibles $2.841M $2.790M
YoY Change -8.28%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $3.541M $3.490M $3.980M
YoY Change -6.77% -12.3% 2.92%
TOTAL ASSETS
Total Short-Term Assets $1.805M $298.0K $2.800M
Total Long-Term Assets $3.541M $3.490M $3.980M
Total Assets $5.346M $3.788M $6.780M
YoY Change -24.41% -44.12% 62.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $210.0K $260.0K $530.0K
YoY Change -73.08% -50.94% 23.26%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $20.00K $20.00K $20.00K
YoY Change 0.0% 0.0% -88.24%
Total Short-Term Liabilities $891.2K $355.5K $760.0K
YoY Change -22.95% -53.22% 10.39%
LONG-TERM LIABILITIES
Long-Term Debt $1.920M $30.00K $60.00K
YoY Change 3740.0% -50.0% -25.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $1.923M $29.80K $60.00K
YoY Change 3613.32% -50.33% -24.81%
TOTAL LIABILITIES
Total Short-Term Liabilities $891.2K $355.5K $760.0K
Total Long-Term Liabilities $1.923M $29.80K $60.00K
Total Liabilities $2.815M $385.3K $820.0K
YoY Change 132.9% -53.01% 6.74%
SHAREHOLDERS EQUITY
Retained Earnings -$24.24M -$23.49M
YoY Change 42.33%
Common Stock $817.00 $818.00
YoY Change 5.01%
Preferred Stock
YoY Change
Treasury Stock (at cost) $623.0K $623.0K
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity $2.532M $3.403M $5.960M
YoY Change
Total Liabilities & Shareholders Equity $5.346M $3.788M $6.780M
YoY Change -24.41% -44.12% 62.94%

Cashflow Statement

Concept 2015 Q4 2015 Q3 2014 Q3
OPERATING ACTIVITIES
Net Income -$750.0K -$578.5K -$2.470M
YoY Change -76.71% -76.57% 183.59%
Depreciation, Depletion And Amortization $130.0K $130.0K $130.0K
YoY Change 85.71% 0.0% 44.44%
Cash From Operating Activities -$670.0K -$1.020M -$2.100M
YoY Change -67.16% -51.43% 600.0%
INVESTING ACTIVITIES
Capital Expenditures -$190.0K -$60.00K -$140.0K
YoY Change -258.33% -57.14%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$190.0K -$60.00K -$140.0K
YoY Change -371.43% -57.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.500M -10.00K 3.880M
YoY Change 67.79% -100.26% 2055.56%
NET CHANGE
Cash From Operating Activities -670.0K -1.020M -2.100M
Cash From Investing Activities -190.0K -60.00K -140.0K
Cash From Financing Activities 2.500M -10.00K 3.880M
Net Change In Cash 1.640M -1.090M 1.640M
YoY Change -441.67% -166.46% -1466.67%
FREE CASH FLOW
Cash From Operating Activities -$670.0K -$1.020M -$2.100M
Capital Expenditures -$190.0K -$60.00K -$140.0K
Free Cash Flow -$480.0K -$960.0K -$1.960M
YoY Change -77.78% -51.02% 553.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4161269 USD
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Trading Symbol
TradingSymbol
AEYE
CY2015Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
81800488 shares
CY2015Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
651 USD
CY2015Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2789832 USD
CY2014Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3097293 USD
CY2015Q3 us-gaap Goodwill
Goodwill
700528 USD
CY2014Q4 us-gaap Goodwill
Goodwill
700528 USD
CY2015Q3 us-gaap Assets
Assets
3788371 USD
CY2014Q4 us-gaap Assets
Assets
7072537 USD
CY2015Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
262148 USD
CY2014Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
779891 USD
CY2015Q3 us-gaap Billings In Excess Of Cost Current
BillingsInExcessOfCostCurrent
66896 USD
CY2014Q4 us-gaap Billings In Excess Of Cost Current
BillingsInExcessOfCostCurrent
123908 USD
CY2014Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
228983 USD
CY2015Q3 us-gaap Liabilities Current
LiabilitiesCurrent
355544 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1156782 USD
CY2015Q3 us-gaap Long Term Debt
LongTermDebt
29800 USD
CY2014Q4 us-gaap Long Term Debt
LongTermDebt
51800 USD
CY2015Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
29800 USD
CY2014Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
51800 USD
CY2015Q3 us-gaap Liabilities
Liabilities
385344 USD
CY2014Q4 us-gaap Liabilities
Liabilities
1208582 USD
CY2015Q3 us-gaap Preferred Stock Value
PreferredStockValue
2 USD
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q3 us-gaap Common Stock Value
CommonStockValue
818 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
778 USD
CY2015Q3 us-gaap Treasury Stock Value
TreasuryStockValue
623000 USD
CY2014Q4 us-gaap Treasury Stock Value
TreasuryStockValue
623000 USD
CY2015Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
27515795 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
23516463 USD
CY2015Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-23490588 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17030286 USD
CY2015Q3 us-gaap Stockholders Equity
StockholdersEquity
3403027 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
5863955 USD
CY2015Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3788371 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7072537 USD
CY2015Q3 us-gaap Cash
Cash
51910 USD
CY2014Q4 us-gaap Cash
Cash
1672901 USD
CY2015Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
49014 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
261676 USD
CY2015Q3 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
54250 USD
CY2014Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
10000 USD
CY2015Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
13800 USD
CY2014Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
13800 USD
CY2015Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
50000 USD
CY2014Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
50000 USD
CY2015Q3 aeye Subscription Receivable
SubscriptionReceivable
0 USD
CY2014Q4 aeye Subscription Receivable
SubscriptionReceivable
1175000 USD
CY2015Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
79037 USD
CY2015Q3 us-gaap Assets Current
AssetsCurrent
298011 USD
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
90688 USD
dei Entity Registrant Name
EntityRegistrantName
AUDIOEYE INC
CY2014Q4 us-gaap Assets Current
AssetsCurrent
3274065 USD
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2015-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Entity Central Index Key
EntityCentralIndexKey
0001362190
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Document Type
DocumentType
10-Q
CY2015Q3 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
24000 USD
CY2014Q4 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
24000 USD
CY2015Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
2500 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-6515848 USD
CY2015Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
81 USD
CY2014Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-416 USD
us-gaap Sales Revenue Net
SalesRevenueNet
314146 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-6463647 USD
us-gaap Sales Revenue Net
SalesRevenueNet
279364 USD
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-22000 USD
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1548851 USD
CY2015Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
128381 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
391958 USD
CY2014Q3 us-gaap Revenues
Revenues
187766 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
902212 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3097293 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-578624 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2457101 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
3345 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-7860 USD
CY2015Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
81 USD
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12416 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3345 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-19860 USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-578543 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-2469517 USD
CY2014Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
132104 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
396269 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
347954 USD
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
365554 USD
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
2380408 USD
us-gaap Operating Expenses
OperatingExpenses
5599405 USD
us-gaap Operating Expenses
OperatingExpenses
6160663 USD
us-gaap Net Income Loss
NetIncomeLoss
-6460302 USD
us-gaap Net Income Loss
NetIncomeLoss
-6535708 USD
CY2015Q3 us-gaap Sales Revenue Net
SalesRevenueNet
108685 USD
CY2014Q3 us-gaap Sales Revenue Net
SalesRevenueNet
186641 USD
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
396268 USD
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
347954 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1200459 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1538557 USD
aeye Common Stock Issuance Costs
CommonStockIssuanceCosts
679972 USD
CY2015Q3 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
0 USD
CY2014Q3 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
1125 USD
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
0 USD
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
5375 USD
CY2015Q3 us-gaap Revenues
Revenues
108685 USD
us-gaap Revenues
Revenues
314146 USD
us-gaap Revenues
Revenues
284739 USD
CY2015Q3 us-gaap Cost Of Revenue
CostOfRevenue
321755 USD
CY2014Q3 us-gaap Cost Of Revenue
CostOfRevenue
264459 USD
us-gaap Cost Of Revenue
CostOfRevenue
1178388 USD
us-gaap Cost Of Revenue
CostOfRevenue
639924 USD
CY2015Q3 us-gaap Gross Profit
GrossProfit
-213070 USD
CY2014Q3 us-gaap Gross Profit
GrossProfit
-76693 USD
us-gaap Gross Profit
GrossProfit
-864242 USD
us-gaap Gross Profit
GrossProfit
-355185 USD
CY2015Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
171594 USD
CY2014Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
546265 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
747990 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1068353 USD
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
92857 USD
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
153188 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
293877 USD
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
-27278 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4352398 USD
aeye Common Stock Issuance Costs
CommonStockIssuanceCosts
778927 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1155 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-212662 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-169179 USD
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
44250 USD
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-54750 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-11651 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
167873 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-517743 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
79792 USD
us-gaap Increase Decrease In Billing In Excess Of Cost Of Earnings
IncreaseDecreaseInBillingInExcessOfCostOfEarnings
-57012 USD
us-gaap Increase Decrease In Billing In Excess Of Cost Of Earnings
IncreaseDecreaseInBillingInExcessOfCostOfEarnings
202967 USD
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-226483 USD
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-243424 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4804778 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3761724 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
88156 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
556611 USD
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-172000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-88156 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-556611 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
325000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1305689 USD
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
1750000 USD
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 USD
aeye Increase Decrease In Stock Subscription Receivable
IncreaseDecreaseInStockSubscriptionReceivable
-1175000 USD
aeye Increase Decrease In Stock Subscription Receivable
IncreaseDecreaseInStockSubscriptionReceivable
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3271943 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4623210 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1620991 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
304875 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1672901 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1847004 USD
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
51910 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2151879 USD
us-gaap Interest Paid
InterestPaid
307 USD
us-gaap Interest Paid
InterestPaid
7444 USD
aeye Marketable Securities Received For Accounts Receivable
MarketableSecuritiesReceivedForAccountsReceivable
0 USD
aeye Marketable Securities Received For Accounts Receivable
MarketableSecuritiesReceivedForAccountsReceivable
60000 USD
aeye Deemed Dividend Beneficial Conversion Feature On Convertible Preferred Stock
DeemedDividendBeneficialConversionFeatureOnConvertiblePreferredStock
594641 USD
aeye Deemed Dividend Beneficial Conversion Feature On Convertible Preferred Stock
DeemedDividendBeneficialConversionFeatureOnConvertiblePreferredStock
0 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2015Q1 aeye Units Sold To Accredited Investors
UnitsSoldToAccreditedInvestors
812500 shares
CY2015Q1 aeye Proceeds From Units Sold To Accredited Investors
ProceedsFromUnitsSoldToAccreditedInvestors
325000 USD
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
43943 USD
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
2810272 shares
aeye Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
109855 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y2M16D
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y9M14D
CY2015Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-299811 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1200459 USD
CY2014Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
311149 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1538557 USD
CY2015Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
568414 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2015Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1297829 USD
CY2015Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2789832 USD
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
CY2015Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
81800488 shares
CY2014Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
61062150 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
80007507 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
55993097 shares
CY2015Q1 aeye Accredited Investors Number
AccreditedInvestorsNumber
1 pure
CY2015Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
0 USD
CY2014Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-12000 USD
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
0 USD
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-12000 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
35000 USD
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
3524521 USD
aeye Warrants Issued1
WarrantsIssued1
0 USD
aeye Warrants Issued1
WarrantsIssued1
21514 USD
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <u><font style="FONT-SIZE: 10pt">Reclassification</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Certain prior year amounts have been reclassified to conform to the current year presentation.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015Q1 aeye Exercise Price Of Units
ExercisePriceOfUnits
0.60
CY2015Q1 aeye Units Sold To Accredited Investors Warrant Term
UnitsSoldToAccreditedInvestorsWarrantTerm
P5Y
CY2015Q1 aeye Units Sold To Accredited Investors Common Stock
UnitsSoldToAccreditedInvestorsCommonStock
1 shares
aeye Units Sold To Accredited Investors Common Stock
UnitsSoldToAccreditedInvestorsCommonStock
1 shares
CY2015Q3 aeye Working Capital Amount
WorkingCapitalAmount
57533 USD
CY2015Q2 aeye Proceeds From Units Sold To Accredited Investors
ProceedsFromUnitsSoldToAccreditedInvestors
1750000 USD
CY2015Q2 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.05 pure
CY2015Q2 aeye Deemed Dividend Beneficial Conversion Feature On Convertible Preferred Stock
DeemedDividendBeneficialConversionFeatureOnConvertiblePreferredStock
594641 USD
CY2015Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 USD
CY2014Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
594641 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 USD
CY2015Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-578543 USD
CY2014Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2469517 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7054943 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6535708 USD
CY2015Q3 us-gaap Officers Compensation
OfficersCompensation
175000 USD
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
500000 shares
CY2011Q4 aeye Loan Term Period
LoanTermPeriod
P4Y
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
81800488 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
77817861 shares
CY2015Q3 aeye Shares Not Expected To Be Earned
SharesNotExpectedToBeEarned
250000 shares
CY2015Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
81800488 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
77817861 shares
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2015Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2015Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2015Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
175000 shares
CY2015Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
175000 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares

Files In Submission

Name View Source Status
0001144204-15-065489-index-headers.html Edgar Link pending
0001144204-15-065489-index.html Edgar Link pending
0001144204-15-065489.txt Edgar Link pending
0001144204-15-065489-xbrl.zip Edgar Link pending
aeye-20150930.xml Edgar Link completed
aeye-20150930.xsd Edgar Link pending
aeye-20150930_cal.xml Edgar Link unprocessable
aeye-20150930_def.xml Edgar Link unprocessable
aeye-20150930_lab.xml Edgar Link unprocessable
aeye-20150930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v424362_10q.htm Edgar Link pending
v424362_ex31-1.htm Edgar Link pending
v424362_ex32-1.htm Edgar Link pending